Keywords 3-1 * |
|
|
|
04 |
|
Chronic progressive diseases |
|
05 |
|
Circulatory failure・Circulatory disturbance |
|
06 |
|
Metabolic disorder・Degenerative disorder |
|
07 |
|
Transplantation pathology |
|
08 |
|
Intractable and rare diseases |
|
09 |
|
Congenital disorder・Developmental anomaly |
|
|
|
|
13 |
|
Intraoperative consultation |
|
14 |
|
Differential diagnosis |
|
15 |
|
Immunohistochemistry・Diagnostic molecular pathology |
|
16 |
|
Classification of Diseases |
|
17 |
|
Evaluation of treatment effects・Therapeutic strategies |
|
18 |
|
Epidemiology・Statistics |
|
19 |
|
Image analysis・AI・Digital pathology |
|
20 |
|
Information technology・Bioinformatics |
|
21 |
|
Education・Medical staff |
|
|
|
24 |
|
Chromosomal abnormality・Hereditary diseases |
|
|
26 |
|
Genetic risks・Environmental factors |
|
27 |
|
Genetic mutation・Carcinogenesis |
|
28 |
|
Gene expression・Epigenetics |
|
29 |
|
Signal transduction・Cell proliferation・Cell cycle |
|
30 |
|
Cell death・Cell damage・Senescence |
|
31 |
|
Invasion and metastasis |
|
32 |
|
Cancer microenvironment・Cancer stem cells |
|
33 |
|
Cancer cellular characteristics |
|
|
35 |
|
Diagnostic markers・Tumor markers・New therapies |
|
36 |
|
Cell biology・Molecular imaging |
|
37 |
|
Cell differentiation・Regenerative medicine |
|
38 |
|
Development and developmental abnormalities |
|
|
40 |
|
Autoimmunity・Autoinflammation |
|
41 |
|
Novel technology・Experimental technique |
|
|